Role of bilastine in allergic rhinitis: a review

Rachna Dhingra

doi:10.18203/issn.2454-5929.ijohns20200166

Authors

Rachna Dhingra Department of ENT, G.G.S. Medical College, Faridkot, Punjab, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20200166

Keywords:

Allergic rhinitis, Histamine, Bilastine

Abstract

The prevalence of allergic diseases is increasing globally, most particularly in middle to low-income countries. Allergic rhinitis and urticaria are common allergic diseases that may have a major negative impact on patient’s quality of life. Bilastine, a novel new-generation antihistamine that is highly selective for the H1 histamine receptor, has a rapid onset and prolonged duration of action. In the fasting state bilastine is quickly absorbed, but the absorption is slowed when it is taken with food or fruit juice. Therefore, it is recommended that bilastine is taken at least one hour before and no sooner than two hours after a meal. This review article describes about the role of bilastine in allergic reactions.

Metrics

Metrics Loading ...

References

Pawankar R, Canonica GW, Holgate ST, Lockey BS, Blaiss WS. World Allergy Association (WAO) White Book on Allergy. United States: World Allergy Organization; 2013.

Bousquet J, Van CP, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108:147-334.

Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. The 2017 revision and update. Allergy. 2018;73:1393-414.

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the world health organization, GA (2) LEN and allerGen). Allergy. 2008;63(86):8-160.

Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol. 2011;106:12-6.

Bilastine. Available at: https://www.pubchem.ncbi. nlm.nih.gov/compound/Bilastine. Accessed on 3 June 2019.

Product Monograph Including Patient Medication Information. Blexten®. Available at: https://www. aralez.com/wp-content/uploads/2016/12/ BLEXTEN-Product-Monography-English.pdf. Accessed on 3 June 2019.

Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(86):8-160

Pawankar R, Bunnag C, Khaltaev N, Bousquet J. Allergic rhinitis and its impact on asthma in Asia Pacific and the ARIA update 2008. World Allergy Organ J. 2012;5(3):212-7.

Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med. 2000;162(4):1391-6.

Meltzer EO, Blaiss MS, Naclerio RM, Stoloff SW, Derebery MJ, Nelson HS, et al. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012;33(1):113-41.

Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy. 2007;62(85):17-25.

Kuna P, Bachert C, Nowacki Z, van Cauwenberge P, Agache I, Fouquert L, et al. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study. Clin Exp Allergy. 2009;39:1338-47.

Bachert C, Kuna P, Sanquer F, Ivan P, Dimitrov V, Gorina MM, et al. Bilastine International Working Group. Comparison of the efficacy and safety of bilastine 20 mg vs desloratadine 5 mg in seasonal allergic rhinitis patients. Allergy. 2009;64:158-65.

Horak F, Zieglmayer P, Zieglmayer R, Lemell P. The effects of bilastine compared with cetirizine, fexofenadine, and placebo on allergeninduced nasal and ocular symptoms in patients exposed to aeroallergen in the Vienna Challenge Chamber. Inflamm Res. 2010;59:391-8.

Sastre J, Mullol J, Valero A; Bilastine Study Group. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis. Curr Med Res Opin. 2012;28:121-30.

Ridolo E, Montagni M, Bonzano L, Incorvaia C, Canonica GW. Bilastine: New insight into antihistamine treatment. Clin Mol Allergy. 2015;13:1.